Free Trial

What Octave Specialty Group (OSG) Said on Its Q3 Earnings Call

Octave Specialty Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Octave sharply narrowed its Q3 loss: Adjusted net loss improved to $1.3 million, or $0.03 per share, from $10 million a year earlier, while adjusted EBITDA swung to $3.3 million. Lower corporate and interest expenses, organic growth, and the ArmadaCare acquisition supported the improvement.
  • Insurance distribution growth exceeded expectations: Revenue rose 35% to $58 million, including 23% organic growth. Management said it expects to exceed full-year guidance for both organic growth and the segment’s $45 million adjusted EBITDA.
  • Everspan improved, though the market is becoming more competitive: Its combined ratio fell to 100.6% from 112.9%, and management expects it to meet or exceed its $6 million adjusted EBITDA target. Octave also expects a nearly $4 million gain from selling a subsidiary, while reaffirming its goal of positive adjusted net income per share in 2026.
  • Five stocks we like better than Octave Specialty Group.

Octave Specialty Group NYSE: OSG narrowed its third-quarter loss as growth in its insurance distribution business, lower corporate expenses and reduced interest costs helped lift adjusted earnings.

The company reported a net loss to shareholders of $13.8 million, or $0.31 per share, for the third quarter of 2026. That compared with a loss from continuing operations to shareholders of $31.7 million, or $0.65 per share, a year earlier.

Adjusted EBITDA to shareholders rose to $3.3 million from a loss of $2.9 million, while the adjusted net loss narrowed to $1.3 million, or $0.03 per share, from $10 million, or $0.21 per share.

Chief Financial Officer David Trick said the improvement reflected organic growth across the business segments, the acquisition of ArmadaCare, lower corporate expenses and reduced interest expense. Octave’s adjusted corporate expenses fell to $7.3 million from $9.5 million a year earlier.

Distribution Growth Supports Outlook

Insurance distribution revenue climbed 35% to $58 million, including 23% organic growth. President and Chief Executive Officer Claude LeBlanc attributed the increase to organic growth and the October 2025 acquisition of ArmadaCare.

The segment’s adjusted EBITDA to shareholders rose nearly 40% to $8.3 million, and its adjusted EBITDA margin increased to 14.2% from 13.9%. The segment still reported a net loss to shareholders of $4.2 million, compared with a $5.4 million loss a year earlier.

Trick said year-to-date organic growth was just over 35%, putting the company on track to exceed its full-year guidance of more than 25%. He also confirmed that Octave expects to exceed its $45 million full-year insurance distribution adjusted EBITDA guidance and anticipates double-digit organic growth in the fourth quarter.

ArmadaCare will begin contributing to the organic growth calculation in November, after the anniversary of its acquisition. Trick said the business is seasonal and is likely to have a smaller impact in the fourth quarter, but he expects a “rather significant favorable impact” on organic growth in the first quarter of 2027.

LeBlanc said accident and health accounts for about a third of Octave’s portfolio and provides diversification from the property and casualty pricing cycle. He said double-digit rate increases in accident and health, driven by rising health care costs, are supporting growth.

Everspan Improves as Premium Mix Shifts

Octave’s specialty property and casualty business, Everspan, reported adjusted EBITDA to shareholders of $2.2 million, compared with less than $0.1 million a year earlier. Gross premiums written increased 2% to $99 million, while net premiums written and earned each reached $26 million, up 44% and 52%, respectively.

Everspan’s combined ratio improved to 100.6% from 112.9%, driven by a lower loss ratio. Its expense ratio increased, however, reflecting higher acquisition costs associated with a growing mix of high-retention programs and higher general and administrative expenses, Trick said.

Trick said full-year gross premiums written could fall slightly short of the company’s $410 million guidance because of changes in business mix and the timing of new program launches. He said Everspan was positioned to meet or exceed its $6 million full-year adjusted EBITDA guidance.

After the quarter ended, Everspan agreed to sell its Providence Washington Insurance Company subsidiary in a transaction expected to close by early next year. Trick said Octave expects a consolidated net gain of nearly $4 million and an approximately $11 million increase in Everspan’s tangible book value when the sale closes.

Management Sees Softer Insurance Market

LeBlanc said abundant capacity has made the property and casualty market more competitive, with global commercial rates declining for a ninth consecutive quarter. Property rates fell roughly 10% in the third quarter, he said, while some casualty and specialty classes continued to see increases.

Despite the softer market, LeBlanc said Octave’s 2027 capacity is largely lined up and that the company expects to be oversubscribed. He also said all of Octave’s managing general agencies are on their target technology platforms and that the rollout of AI-driven submission intake across U.S. agencies is largely complete.

Octave did not formally update its 2026 guidance. Trick said the company remains on track for its first year of positive adjusted net income per share since launching its property and casualty strategy in 2021. LeBlanc also reiterated a target of $80 million in consolidated adjusted EBITDA to shareholders in 2028.

About Octave Specialty Group (NYSE:OSG)

Octave Specialty Group Inc. is a specialty insurance company that provides underwriting solutions for complex, specialized and difficult-to-place risks. The company operates through specialty insurance platforms designed to serve customers and distribution partners seeking coverage outside standard commercial insurance markets. Its business activities include the development, underwriting and management of specialty insurance products across selected lines of business. Octave's offerings are intended for niche risks that may require specialized expertise, tailored policy structures and disciplined risk selection.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Octave Specialty Group Right Now?

Before you consider Octave Specialty Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Octave Specialty Group wasn't on the list.

While Octave Specialty Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines